Workflow
医用分子筛制氧机
icon
Search documents
研判2025!中国医用分子筛制氧行业产业链、产业现状、重点企业及未来趋势分析:人口老龄化加剧,加速推动医用分子筛制氧产业发展[图]
Chan Ye Xin Xi Wang· 2025-04-19 02:15
Industry Overview - Molecular sieve oxygen production, also known as pressure swing adsorption oxygen production, is a type of ambient temperature air separation technology that utilizes the larger diameter of nitrogen molecules to separate oxygen from air [1][2] - The demand for medical oxygen is continuously growing due to the aging population, increasing chronic disease patients, and the strengthening of grassroots medical institutions [1][11] - The market size of China's medical molecular sieve oxygen industry has expanded from 220 million yuan in 2018 to 425 million yuan in 2024 [1][11] Industry Status - The aging population in China is projected to reach 22.023 million people aged 65 and above by 2024, increasing from 8.9% in 2010 to 15.6% of the total population [9] - The medical molecular sieve oxygen industry has developed a complete industrial chain, including raw material supply, production, and application of oxygen machines [7][11] Competitive Landscape - Major companies in the medical molecular sieve oxygen market include Yuyue Medical, Tai Rui Medical, and Mindray Medical, which leverage strong technical capabilities and brand influence to capture significant market shares [13][14] - New and emerging companies are adopting differentiated strategies to compete, focusing on specific niches or customized services [13] Development Trends - The market for medical molecular sieve oxygen machines is expected to grow significantly, with projections indicating a rise to 706 million yuan by 2029 [18] - Technological innovations in new molecular sieve materials are enhancing the performance of oxygen machines, leading to faster adsorption speeds and improved user experience [19] - Government policies supporting the medical health industry, including funding subsidies and tax incentives, are accelerating technological advancements and industry upgrades [20]
直击CMEF2025!36家企业抢先看:西门子、开立、迈瑞……
思宇MedTech· 2025-04-02 10:06
报名:首届全球眼科大会 | 议程更新 报名:首届全球心血管大会 | 奖项申报 报名:首届全球骨科大会 | 奖项评选 合作伙伴征集:2025全球手术机器人大会 2025年4月8日至11日, 第91届中国国际医疗器械(春季)博览会(CMEF) 将在上海国家会展中心拉开帷幕。作为亚太地区规模最大的医疗科技展会,CMEF始终 是行业风向标,不仅汇聚全球创新技术,更见证着产业发展的新趋势。本届展会预计吸引 全球30多个国家和地区的近 5000家 企业,携 数万款 前沿产品集中亮相 ,以"创新科技,智领未来"为主题,共同探讨医疗科技的突破与未来。 CMEF不仅是一场产品与技术的集中展示,更是医疗行业生态的一次深度联动。从人工智能驱动的医学影像,到手术机器人赋能精准医疗,从智慧医院建设,到国 产医疗设备的崛起,CMEF2025通过高规格论坛、产业对话和技术展示,构建起全方位的交流平台,为行业发展提供新的思路与动能。 在这一医疗科技的年度盛会上,哪些企业将携最新技术亮相?哪些创新产品值得重点关注? 思宇梳理了本届CMEF的亮点企业,一起来看它们如何在这场科技盛宴 中抢占先机! P.S. 展位图附于文末,感兴趣的读者可按图索骥 ...